The North American Non-Knowledge Based Clinical Decision Support System (CDSS) Market Is Expected to Reach $20.0 Million by 2018 - New Report by MicroMarket Monitor

Share Article

The North American Non-knowledge Based/Evidence-Based Clinical Decision Support System (CDSS) market is driven by favorable government initiatives to better streamline the healthcare solutions and reduce the healthcare costs

MicroMarket Monitor

MicroMarket Monitor

Key Players in the North American Non-Knowledge Based Clinical Decision Support System (CDSS) market are Cerner Corporation, Athenahealth, Inc., McKesson Corporation, and Zynx Health Incorporated.

The North American Non-Knowledge Based Clinical Decision Support System (CDSS) market report defines and segments the market in North America with analysis and forecast of revenue. The Knowledge-based/evidence-based CDSS market in North America is expected to reach around $20.0 million by 2018, at a CAGR of 2.1% from 2013 to 2018.

Browse through the TOC of the North American non-knowledge based clinical decision support system (CDSS) market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the market segmentation, and is supported by various tables and figures.

The non-knowledge based CDSS uses a form of artificial intelligence called machine learning, which makes decisions based on historic experience and finds patterns in clinical data. The system analyzes patterns found in patient data, which eliminates the need for writing rules and the need for expert advice on any particular issue. The clinical decision support system (CDSS) was introduced as an efficient solution that can offer personalized medicine at the point of care.

However, this system cannot elaborate the reasons behind selection of data, which might lead to medication errors. Due to this, most clinicians do not use this system for decision-making. Hence, the demand for such models is likely to decrease in coming years. Furthermore, in comparison to knowledge-based CDSS, non-knowledge-based models perform study on limited diseases at one time. This would further restrict the prospects of this market.

Speak to Analyst @

The U.S. is currently facing a major challenge in countering the growing healthcare costs. The growing healthcare costs have pressurized the healthcare industry to provide optimum solutions. Therefore, the rate of adoption of healthcare IT solutions, mainly, CDSS, has increased which ultimately helps the non-knowledge-based CDSS market to grow. Besides, the growing need to integrate healthcare systems will also drive the market.
This market is segmented and forecast on the basis of components and deployments of knowledge-based CDSS market in the North American region. On the basis of products the market is divided as integrated and standalone knowledge-based/evidence-based CDSS market. The components comprise hardware, software, and services, and the deployments are on-premise, cloud-based, and web-based. The market is further segmented and forecast on the basis of major countries, such as the U.S., Canada, and Mexico. The market is also segmented and analyzed further on the basis of the major application and end-users.

Early buyers will receive 10% customization on this report.

This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies of the market.

Related Reports :

European Non-Knowledge based CDSS Market

The European non-knowledge based CDSS market was valued at $3 million in 2012, and expected to be $3.4 million by 2018, at a CAGR of 2.2%.
The report ‘European Non-Knowledge based CDSS Market forecast, 2012-2018’ analyzes the market by sub-segments integrated non-knowledge based CDSS and standalone non-knowledge based CDSS. Integrated CDSS accounted for about 70% of the total market. The non-knowledge based CDSS market can also be segmented based upon components into hardware, software, and services.

The European market accounted for 13% of the total market. Germany accounted for 25% of the total European non-knowledge based CDSS market, followed by France at 20%.

The major driver for the European non-knowledge based CDSS market is the increasing demand for analytical IT solutions that help in point-of-care decision making. The implementation of such solutions has resulted into reduction of cost and improvement in the quality of care provided. Other factors responsible for the growth of the market are the increasing government initiatives and introduction of various incentive plans for healthcare providers.

About MicroMarket Monitor :

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Chandrasekhar K.
Follow >
Micro Market Monitor
Like >
Follow us on
Visit website